GW Pharma to launch first CBD-based epilepsy drug in Europe 'over the next

Medications
1

I think GW pharma might have given up on CBD for schizophrenia. But I’m not sure.

4 Likes
2

Now this sounds interesting.

1 Like
3

Echo pharma is still on… !!! let’s see …

4

Not sure cannabis will lead anywhere for sz. Good for epilepsy it seems for sure and I’ve heard first hand testimony about how effective it is for treatment of those disorders. Sz. Not sure it’s a functional end but research and money is being spent. We will see.

2 Likes
5

Epidyolex comes in 100ml bottles with 100mg p/ml CBD.

In clinical trials for schizophrenia 600 up to 1600mg is used.

Damn that I got caught prescribing myself offlabel medication or I’ve would have tried this to see what happens.